SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-031601
Filing Date
2022-09-14
Accepted
2022-09-14 08:09:37
Documents
14
Period of Report
2022-09-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-8k_20220914.htm   iXBRL 8-K 44349
2 EX-99.1 tcon-ex991_15.htm EX-99.1 18405
3 GRAPHIC gjpdliqktj3e000001.jpg GRAPHIC 12142
  Complete submission text file 0001564590-22-031601.txt   213593

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tcon-20220914.xsd EX-101.SCH 5605
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20220914_lab.xml EX-101.LAB 19326
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20220914_pre.xml EX-101.PRE 11500
8 EXTRACTED XBRL INSTANCE DOCUMENT tcon-8k_20220914_htm.xml XML 3564
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 221242105
SIC: 2836 Biological Products, (No Diagnostic Substances)